Medinol

Medinol is a privately held company founded in 1992 by Dr. Judith Richter and Dr. Jacob (Kobi) Richter. The company specializes in developing and manufacturing innovative cardiovascular medical devices, particularly stents for interventional cardiology. With over 300 employees and offices in the U.S. and Israel, Medinol manages a fully integrated process that includes research, development, manufacturing, quality control, regulatory affairs, clinical trials, marketing, and sales. Medinol is known for its pioneering stent technology, holding over 400 patents and having delivered more than 2 million stents worldwide. Its flagship product, the NIR stent, was introduced in 1996 and has been extensively studied in clinical trials. The company offers a range of products, including drug-eluting stents, structural heart devices, and implantable microsensors. Medinol employs proprietary QualitySurface™ technology to ensure high safety and consistency in its products, establishing itself as a significant player in the cardiovascular intervention market. Its customers include interventional cardiologists and healthcare providers focused on treating cardiovascular diseases.

• Employees 140
• Founded 1992
• Annual Revenue $50000000